An increased lung cancer risk has been described among foundry workers. Polycyclic aromatic hydrocarbons (PAHs) and silica are possible aetiological factors. This study describes a urinary PAH metabolite, 1-hydroxypyrene (hpU), as well as the degree of cytochrome P450IA2 activity/induction as reflected by the urinary caffeine ratio (IA2) in 45 foundry workers and 52 controls; IA2 was defined as the ratio ofparaxanthine 7-demethylation products to a paraxanthine 8-hydroxylation product (1,7-dimethyluric acid). Mean exposure concentrations for foundry workers were defined by breathing zone hygienic samples (respirable dust 1-2 to 3 52 mg/m3 (93 samples)) and as total PAH (0-46 pg/m3) and pyrene concentrations (0-28 pg/m3) (six samples). Non-smoking controls and foundry workers had similar IA2 ratios (5-63, 95% confidence interval (95% CI) 4 56-6 70 and 4 40, 95% CI 3-56-5-24). The same was true for smoking controls and foundry workers (910, 95% CI 8-00-10-20 and 8-69, 95% CI 7-37-10-01). Both smoking groups had raised 1A2 ratios compared with non-smokers (p < 0-01). Nonsmoking controls and foundry workers had similar hpU concentrations (0-16, 95% CI 0 10- Increased hpU concentrations in smoking foundry workers suggest a more than additive effect from smoking and foundry exposures resulting in increased PAH uptake. Increased P45OIA2 enzyme activity was only found in smokers and no additional effect of foundry exposures was seen. These data suggest that smoking as well as work related PAH exposure may be causally related to increased risk of lung cancer in foundry workers.
0-22 and 0-11, 95% CI 0-09-0-13 umol/mol creatinine). Smoking foundry workers had raised hpU concentrations (0A42, 95% CI 0-25-0-59) compared with smoking controls (0-26, 95% CI 0-18-0'34) (p < 0-01). A small subgroup of smoking foundry workers with the highest exposures to both silica and PAH also had the highest hpU concentrations (0 70, 95% CI -0-07-1A47 pmol/mol creatinine) (p < 0-04).
Increased hpU concentrations in smoking foundry workers suggest a more than additive effect from smoking and foundry exposures resulting in increased PAH uptake. Increased P45OIA2 enzyme activity was only found in smokers and no additional effect of foundry exposures was seen. These data suggest that smoking as well as work related PAH exposure may be causally related to increased risk of lung cancer in foundry workers.
Many studies have shown an increased risk of lung cancer among iron foundry workers (for example'"3).
A working group of the International Agency for Research on Cancer described iron founding as a cause of lung cancer in humans.4 Polycyclic aromatic hydrocarbons (PAHs) from heated moulds may be an aetiological factor.
A urinary metabolite of pyrene, 1 -hydroxypyrene (hpU), has been used to monitor exposure to PAH in road paving and coke oven workers as well as in psoriatic patients treated with coal tar.7 The cytochrome P450IA subfamily is inducible by PAHs as well as responsible for their metabolic activation to ultimate carcinogens.8 Moreover, the content and activity of cytochrome P4501A2 is increased in smokers, an effect thought to be related to PAHs in the smoke.9 This activity can be assessed by measuring the metabolic ratios of dietary caffeine."1'2 The purpose of the present investigation was to compare urinary excretion of hpU and cytochrome P450IA2 activity in foundry workers occupationally exposed to PAHs with unexposed controls. Urine samples (50 ml) were collected from exposed subjects at least five weeks after the summer vacation on two Friday mornings in September 1988 at the foundry. Specimens were stored at -20°C. Urinary metabolites were deconjugated by enzymatic hydrolysis and a solid phase sample clean up was applied. The sum of free and conjugated 1-hydroxypyrene was determined by HPLC analysis and corrected for creatinine. A full description of the method is presented elsewhere.14 The kinetic Jaffe method with a slight variation (final phosphate concentration of 6 6 instead of 4-8 mmol/l) was used to measure creatinine.15
URINARY CAFFEINE METABOLITE DETERMINATIONS
Caffeine is sequentially metabolised by cytochrome P4501A2, N-acetyl transferase (NAT), or xanthine oxidase (XO).' 12 The activity of these three enzymes can be estimated from the ratios of the metabolites of dietary caffeine-for example, the content of a cup of coffee-excreted into the urine. The ratio 1-methylxanthine (1X) plus 1-methyl uric acid (1U) plus acetylformylamino uric acid (AFMU): 1,7-dimethyl uric acid (17U) reflects the P450IA2 activity."12 The ratio AFMU:1X indicates acetylator state, and the ratio lU: lX is a measure of the activity of xanthine oxidase.'°16 An AFMU: 1X ratio of 0 5 or less defined slow acetylators.
The five relevant metabolites of caffeine, AFMU, 1X, 1U, 1,7-dimethylxanthine (17X), and 17U were assayed in duplicate in the urine samples by HPLC as described by Campbell et al.1' Standards were prepared in urine collected from a subject after three days on a xanthine free diet. Pure compounds were used as references: 1X, LU, and 17X were purchased from Sigma (Milwaukee, WI) and 17U from Fluka (Buchs, Switzerland); AFMU was kindly provided by Dr B K Tang, Toronto. Samples ofurine were acidified with HCI to pH 3 5. After addition of 120 mg ammonium sulphate, 200 Id of urine was extracted with 6 ml chloroform isopropanol mixture (90:10 v/v). The organic phase was dried at 40°C under N2. The residue was reconstituted in the eluent (005%/o acetic acid methanol mixture (90:10 v/v)). The analytical column, a Beckman Ultraphere ODS (5 pim, 25 cm), was eluted at 1 ml/min. The effluent was monitored at 280 nm.
During preparation and extraction and after reconstitution all samples were kept below 50C to conserve Smoking, uptake of PAHs, and P4501A2 activity amongfoundry workers Figure 1 shows the mean hpU concentrations according to exposure to silica. All smoking groups had significantly raised mean values compared with their non-smoking counterpart. Smoking foundry workers in both low (0-36, 95% confidence interval (95% CI) 0-26-046) and high (0-47, 95% CI 0-16-0 78) silica exposure groups had significantly higher concentrations than smoking controls (0-26, 95% CI 0-18-0-34). Non-smoking controls (0-16, 950/0 CI 0 08-0 24) had non-significantly higher hpU concentrations than non-smoking foundry workers with either low (0-13, 95% CI 0 08-018) or high (0-08, 95% CI 0-03-013) exposure to silica. Which PAH metabolite is most appropriate for biological monitoring of foundry workers is unknown. We chose 1-hydroxypyrene, a metabolite of pyrene, because it has been used for other populations exposed to PAHs. In the present study pyrene was only 4% (0.28/6-41) oftotal PAHs. Thus another PAH metabolite associated with a higher exposure might be more appropriate.
In our present study smokers had consistently higher hpU concentrations than non-smokers. Other studies have shown both higher (0 17-062 pmol/mol creatinine)6 and similar (0-26-0-28 pmol/mol creatinine)'6 hpU concentrations in smoking controls compared with non-smoking controls. Thus smoking should be controlled for when measuring hpU concentrations.
Only smoking foundry workers had raised hpU concentrations (table 2) . These concentrations were similar to those found in workers exposed to petroleum coke dust (0-54-0 90).26 Higher concentrations have been described, however, in psoriatic patients (25A-1565 0),7 coke oven (0-70-11-2),6 creosote wood (up to about 40).27 and road paving (about 0 5-85)5 workers. These varying concentrations probably reflect different exposures.
Our results suggest a more than additive effect of exposure to PAHs and smoking. Jongeneelen et al reported similar findings among coke oven workers.6 Decreased mucociliary clearance and induced enzyme metabolism among smokers may explain this effect. The data presented in figure 3 suggest an additional effect from simultaneous exposure to PAHs and silica. It is interesting to note that a similar effect has been shown for benzo(a)pyrene serum protein adducts in the identical population.'3
Increased uptake of silica particles with PAHs adsorbed to their surface may explain this phenomenon. 28 The cytochrome P450IA subfamily is thought to play a major part in the activation of foreign chemicals into toxic compounds.29 Of the two enzymes belonging to this family P450IA2 is probably exclusively expressed in the liver whereas P450IA1 is mainly expressed at extrahepatic sites.
The two enzymes are similar in catalytic specificity and inducibility. The PAHs are preferential substrates, however, and inducers of P450IA1, whereas aromatic amines are preferential substrates and inducers of P450IA2."9 In smokers, increased liver microsomal content of P450IA2 as well as in vivo metabolism of its substrate, caffeine, have been shown.9"' In our present study the metabolic ratio of dietary caffeine reflecting the P450IA2 activity in the liver was almost doubled in smokers compared with non-smokers as shown previously."34' Despite the apparent additive effect of exposure to PAHs and smoking in foundry workers on the excretion ofhpU, however, no additive effect regarding the hepatic P450IA2 activity was found. A similar discrepancy between the effect of smoking and occupational exposure to PAHs on the activity of hepatic cytochrome P450, as assessed by the pharmacokinetics of theophylline, has been shown in coke oven workers." Moreover, extensive exposure to sidestream tobacco smoke rich in PAHs also failed to alter theophylline metabolism.'2 A possible explanation might be that inhaled PAHs from the working environment or sidestream smoke is metabolised in the lung and never reaches the liver. Some of the enzyme inducing constituents of mainstream tobacco smoke, however, may either be poor substrates for cytochrome P450 in the lung or reach the liver through portal blood after condensation and swallowing. Also, it has been suggested that the inducing effect of smoking is not related to PAHs but to other smoke ingredients such as carbolines and even higher chlorinated dioxins." A possible inducing effect of PAHs on cytochrome P450IA1 in the lung could not be assessed with the current methods. Such an effect may explain the apparent additive effect of smoking and exposure to PAHs on the excretion of hpU through increased formation.
In all subgroups (table 2) the distribution of slow and fast acetylators was similar and compatible with that of the Danish population.'0 Neither foundry work or smoking had any effect on the activity of xanthine oxidase, which may be implicated in oxidative tissue injury related to ischaemia and infection. '435 Several potential confounding factors should be taken into consideration with regard to the present investigation. Dietary factors were not controlled for, but there is no reason to believe that they had any effect. Ifthe minimal concentrations ofPAHs that can be found in food and drinking water had a measurable effect, it should be similar in both exposed and control groups. Three foundry workers were under treatment with coal tar salve when samples were collected. This minor treatment had no apparent effect as these workers had low hpU concentrations (0-12, 0 30, and 0-13 jumol/mol creatinine). No alcohol abuse was found in either exposed or control subjects. Thus alcohol ingestion was unlikely to have influenced the results. Tests ofliver function were not performed. Women were included in the exposed group but not in the controls. As 1-hydroxypyrene was corrected using creatinine, any potential effect of differing muscle mass between men and women should have been eliminated but potential differences in uptake and metabolism were not evaluated. The metabolic ratios of caffeine are not influenced by sex." '30 Multiple regression analysis showed no effect of either sex or age.
In conclusion our data have shown raised concentrations of pyrene urinary metabolite (hpU) in smoking foundry workers. An additive effect from smoking and foundry exosure is suggested. Increased P450IA2 activity was only seen in smokers with no additional effect of foundry work. These data suggest that smoking as well as work related exposure to PAHs may be causally related to increased risk of lung cancer in foundry workers.
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